Whole-Kidney Three-Dimensional Staining with CUBIC
July 18th, 2022
4.3K views
The present protocol describes a tissue clearing method and whole-mount immunofluorescent staining for three-dimensional (3D) kidney imaging. This technique can offer macroscopic perspectives in kidney pathology, leading to new biological discoveries.
Overview
This protocol allows visualization of three-dimensional structures in full kidney, providing a macroscopic perspective that can lead to innovative discoveries in kidney research. The method includes tissue clearing and whole-mount immunofluorescent staining for enhanced imaging quality.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Pathology
Background
- Whole-mount organ staining is challenging due to antibody penetration difficulties.
- High-quality staining is crucial for accurate 3D imaging.
- This protocol addresses common issues in kidney imaging.
- Macroscopic perspectives can lead to new biological insights.
Purpose of Study
- To develop a reliable method for 3D kidney imaging.
- To enhance visualization of kidney structures.
- To facilitate innovative discoveries in kidney pathology.
Methods Used
- Immersion fixation in 4% paraformaldehyde at 4°C for 16 hours.
- Washing with PBS for two hours each, three times.
- Decolorization and delipidation using 50% CUBIC-L.
- Gentle shaking at room temperature during the delipidation process.
Main Results
- Demonstrated high-quality whole-mount staining of kidneys.
- Improved antibody penetration achieved.
- Provided clear 3D visualization of kidney structures.
- Enabled macroscopic perspectives for better understanding of kidney pathology.
Conclusions
- The protocol successfully enhances kidney imaging techniques.
- It opens avenues for new discoveries in kidney research.
- Future studies can build on this method for further insights.
Frequently Asked Questions
What is the main advantage of this protocol?
The main advantage is its ability to provide high-quality 3D imaging of kidney structures, which can lead to innovative discoveries.
How long does the fixation process take?
The immersion fixation process takes 16 hours at 4°C.
What is the purpose of using CUBIC-L?
CUBIC-L is used for decolorization and delipidation, enhancing antibody penetration for better staining.
Can this method be applied to other organs?
While this protocol is designed for kidneys, similar methods may be adapted for other organs.
What challenges does whole-mount staining address?
It addresses challenges related to antibody penetration and achieving high-quality imaging.
What are the implications of this research?
The implications include potential new insights into kidney pathology and improved research methodologies.
Executive Industry Relevance
Three-dimensional whole-kidney staining with CUBIC enables comprehensive visualization of renal microstructures, overcoming the limitations of conventional pathology. This capability supports high-resolution mapping of blood vessels, tubules, glomeruli, and sympathetic nerves, providing critical insights for early discovery and mechanistic de-risking in renal disease research. The method enhances predictive confidence at key inflection points in preclinical portfolio advancement.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of renal architecture and cellular networks at single-cell resolution.
- Supports biological de-risking by visualizing structural alterations after injury or intervention.
- Facilitates functional target validation through comprehensive mapping of sympathetic nerves and glomeruli.
- Improves predictive confidence for prioritizing renal disease targets.
Screening & Assay Development
- Prepares validated 3D biological systems for downstream imaging and quantification workflows.
- Standardizes whole-organ staining for reproducible, quantitative outputs across studies.
- Enables scalable imaging of rare events and structural changes in kidney tissue.
- Supports reliable evaluation of compound effects on renal microanatomy.
Translational & Preclinical Research
- Aligns 3D imaging outputs with disease-relevant biomarkers such as glomerulomegaly.
- Provides continuity from discovery through preclinical validation by visualizing intervention effects.
- Enables risk-adjusted advancement decisions based on comprehensive tissue analysis.
- Delivers predictive de-risking for translational renal research programs.
Pipeline & Workflow Integration
This whole-kidney 3D staining protocol integrates into the discovery-to-preclinical continuum, supporting hypothesis testing, target validation, and translational biomarker alignment in renal research.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification by mapping renal structures and injury responses.
- Screening: Provides assay-ready, reproducible 3D imaging outputs for quantitative comparison of experimental conditions.
- Analytics: Enables measurement and quantification of structural changes, supporting robust statistical analysis.
- Translational Research: Connects imaging findings to disease models and early biomarker identification.
- Enterprise Reuse: Establishes a reusable platform for whole-organ imaging across renal and related tissue studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in renal target validation.
- Operational Value: Delivers standardized, scalable, and reproducible 3D imaging workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling comprehensive tissue analysis.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of renal disease programs.
Implementation Considerations
- Requires expertise in tissue clearing, immunostaining, and 3D imaging analysis.
- Needs access to advanced imaging instrumentation and computational analysis tools.
- Demands cross-team standardization for reproducibility and data comparability.
- May require adaptation for different organ systems or antibody panels.
- Antibody penetration and staining duration are practical limitations for whole-organ imaging.
Biopharma FAQs
Why does null hypothesis testing matter for 3D kidney structure analysis?
Null hypothesis testing enables objective evaluation of structural changes in renal tissues, supporting robust target validation. By quantifying differences in glomeruli or nerve architecture, teams can distinguish true biological effects from background variability.
How does independent variable isolation fit in whole-kidney staining workflows?
Isolating variables such as injury type or drug intervention allows precise attribution of observed 3D structural changes. This supports mechanistic de-risking and strengthens confidence in discovery-stage findings.
What do quantitative dependent variable measurements enable in CUBIC imaging?
Quantitative measurements of glomerular size, nerve density, or duct morphology enable statistical comparison across experimental groups. These outputs inform go/no-go decisions and facilitate cross-study reproducibility.
Why are replication requirements critical for cross-functional kidney imaging studies?
Replication ensures that 3D imaging results are robust and reproducible across teams, supporting enterprise-wide confidence in structural findings. This is essential for advancing candidates through the R&D pipeline.
What statistical analysis capabilities are needed before implementing 3D kidney quantification?
Teams require statistical tools to analyze volumetric and morphological data, enabling rigorous comparison of experimental conditions. These capabilities underpin reliable interpretation and portfolio decision-making.
Chapters in this video
0:05
Introduction
0:37
Kidney Fixation, Decolorization, and De-Lipidation
1:45
Whole-Mount Immunofluorescent Staining and Refractive Index (RI) Matching
3:03
Results: Whole-Mount Immunofluorescent Staining for Three-Dimensional (3D) Kidney Imaging
4:00
Conclusion
